article

COVID-19 drug development based on boosting immunity

6
SHARES

Posted: 31 December 2020 | | No comments yet

Baidyanath Dash explains the two requirements for COVID-19 drug development: killing the virus and boosting immunity.

Click here to read the article. 

With regular news updates and feature articles, our COVID-19 hub has everything you need to keep up to date with R&D during the pandemic. Click below to visit:

COVID-19 hub